Studies have indicated that the level of proinflammatory cytokines, IL-1β and IL-6, descended significantly in inflammatory bowel disease 39, acute pancreatitis 40 and type 2 diabetes 17 after injection of HUMSCs. This evidence concerns the gene IL6 and type 2 diabetes mellitus.